Skip to main content

Table 1 Rare non-synonymous CLU mutations identified in 74 AD patients

From: Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations

Gene locationa

DNAb

Proteinc

Proteind

dbSNP

This study

Previous study [3]

Protein location

PolyPhen2 (PSIC)

SIFT

PMUT

EVS (EA)

1000GP

Exon 6

c.1079 T > A

p.I360N

p.I308N

1 AD

-

β-chain

Possible (0.677)

Not tolerated (0.00)

Pathological (0.9659)

-

-

Exon 5

c.701G > A

p.R234H

p.R182H

1 AD

2 AD, 1 C

α-chain

Probably (0.995)

Tolerated (0.15)

 

0.0002

0.001

Exon 5

c.764C > T

p.T255I

p.T203I

rs4127629

1 AD

5 AD, 6 C

β-chain

Benign (0.041)

Tolerated (0.29)

Pathological (0.6284)

0.003

0.001

  1. Abbreviations: AD Alzheimer patient, C control individual, AAO Age of Onset, y years
  2. aGene location position according to CLU transcript with 9 coding exons [NM_001831.2]
  3. bNumbering according to CLU mRNA sequence starting at the A of the ATG translation initiation codon in [NM_001831.2]
  4. cNumbering according to CLU protein sequence [NP_001822.2 consisting of 501 AA]
  5. dFor easy comparison to Exome Variant Server, numbering according to updated CLU protein sequence [NP_001822.3 consisting of 449 AA] is given. Mutations were compared to our findings previously described in Belgian patients [3]. Predictions of pathogenicity was performed using Polyphen2 (benign/possibly damaging/probably damaging), SIFT (tolerated/not tolerated) and PMUT (neutral/pathological). Minor allele frequency (MAF) was compared to Exome Variant Server (EVS) in European American individuals (EA) and 1000 GenomesProject (1000GP)